Schalm SW - Search Results

1

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.

de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. de Jongh FE, et al. Among authors: schalm sw. Gastroenterology. 1992 Nov;103(5):1630-5. doi: 10.1016/0016-5085(92)91188-a. Gastroenterology. 1992. PMID: 1426884

2

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.

Flink HJ, van Zonneveld M, Hansen BE, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group. Flink HJ, et al. Among authors: schalm sw. Am J Gastroenterol. 2006 Feb;101(2):297-303. doi: 10.1111/j.1572-0241.2006.00418.x. Am J Gastroenterol. 2006. PMID: 16454834 Clinical Trial.

3

[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].

Janssen HL, Berk L, de Man RA, Heijtink RA, Schalm SW. Janssen HL, et al. Among authors: schalm sw. Ned Tijdschr Geneeskd. 1992 Apr 25;136(17):835-9. Ned Tijdschr Geneeskd. 1992. PMID: 1522928 Dutch.

4

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

Janssen HL, Schalm SW, Berk L, de Man RA, Heijtink RA. Janssen HL, et al. Among authors: schalm sw. J Hepatol. 1993;17 Suppl 3:S47-51. doi: 10.1016/s0168-8278(05)80423-4. J Hepatol. 1993. PMID: 8509639

5

New developments in antiviral therapy for chronic hepatitis B infection.

De Man RA, Heijtink RA, Niesters HG, Schalm SW. De Man RA, et al. Among authors: schalm sw. Scand J Gastroenterol Suppl. 1995;212:100-4. doi: 10.3109/00365529509090307. Scand J Gastroenterol Suppl. 1995. PMID: 8578221 Review.

6

Survival and complications in a cohort of patients with anti-delta positive liver disease presenting in a tertiary referral clinic.

de Man RA, Sprey RP, Niesters HG, Heijtink RA, Zondervan PE, Hop W, Schalm SW. de Man RA, et al. Among authors: schalm sw. J Hepatol. 1995 Dec;23(6):662-7. doi: 10.1016/0168-8278(95)80031-x. J Hepatol. 1995. PMID: 8750164

7

The prognostic significance of subclinical hepatic encephalopathy.

Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. Hartmann IJ, et al. Among authors: schalm sw. Am J Gastroenterol. 2000 Aug;95(8):2029-34. doi: 10.1111/j.1572-0241.2000.02265.x. Am J Gastroenterol. 2000. PMID: 10950053

8

Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.

van Rossum TG, Vulto AG, Hop WC, Schalm SW. van Rossum TG, et al. Among authors: schalm sw. Am J Gastroenterol. 2001 Aug;96(8):2432-7. doi: 10.1111/j.1572-0241.2001.04049.x. Am J Gastroenterol. 2001. PMID: 11513186 Clinical Trial.

9

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

10

Hepatologists have addressed these severe complications of liver diseases in many ways, but unfortunately the impact of old and modern therapies on survival once complications of liver disease are manifest, is only minor. Preface.

Janssen H, Schalm S. Janssen H, et al. Best Pract Res Clin Gastroenterol. 2008;22(6):989-90. doi: 10.1016/j.bpg.2008.12.003. Best Pract Res Clin Gastroenterol. 2008. PMID: 19187862 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters